抑制素依赖的DNA修复和氧化应激反应会损害DIPG细胞的存活率
Sarah A King1, Rana Rheem1, Kathryn M Spitler1
1Free Radical and Radiation Biology Program, Department of Radiation Oncology, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, USA.
Research square
|December 3, 2025
概括
丁醇是一种新型治疗药物,通过增加氧化应激和损害DNA修复,选择性地降低了扩散内在庞丁质瘤 (DIPG) 细胞的存活率. 这种儿童脑瘤药物显示出增强治疗策略的前景.
科学领域:
- 在瘤学瘤学.
- 神经瘤学神经瘤学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 扩散性内在庞丁质瘤 (DIPG) 是侵袭性的儿科脑瘤,通常是由H3K27M突变驱动的.
- 基因组脱乙酶 (HDAC) 是涉及癌症的表观遗传调节剂,使它们成为DIPG的潜在治疗点.
- 这项研究研究了三级HDAC抑制剂sirtinol作为DIPG的潜在治疗方法.
研究的目的:
- 评估sirtinol在患者衍生的DIPG细胞中的疗效和细胞机制.
- 评估sirtinol与正常人星球细胞 (NHAi) 的选择性.
- 为了确定sirtinol对DNA修复途径及其血脑屏障透的作用.
主要方法:
- 在体外研究中利用患者衍生的DIPG和NHAi细胞系.
- 评估了克隆原生存活率,蛋白质表达 (西部斑块) 和酶活性.
- 采用液体染色学并联质谱法 (LC-MS-MS) 来测量sirtinol的大脑和小鼠的血液透率.
主要成果:
- 锡丁醇在DIPG细胞中表现出剂量依赖的细胞毒性,对NHAi细胞的影响最小.
- 结合的sirtinol和辐射在DIPG细胞中显示出添加毒性.
- 锡丁醇诱导过氧化物生成,增加了DNA双链断裂,并抑制了DIPG细胞中ATR介导的DNA修复.
- 在小鼠大脑中检测到sirtinol,这表明血脑屏障的透.
结论:
- 锡丁醇对DIPG细胞具有选择性的抗瘤活性.
- 锡丁醇作为氧化还原调节剂,增强氧化应激并破坏DNA修复机制.
- 锡丁醇显示出作为DIPG的向治疗药物的潜力,可能与放射治疗结合使用.
相关概念视频
DNA Damage can Stall the Cell Cycle
9.9K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.9K
DNA Damage Can Stall the Cell Cycle
3.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.0K
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Negative Regulator Molecules
38.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.2K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K


